The FDA announced that it has approved Tris Pharma’s extended-release amphetamine oral suspension (Dyanavel XR) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged 6 years and older. The drug, developed using the manufacturer’s LiquiXR technology, is now the first and only once-daily, extended-release, amphetamine-based oral liquid to be granted FDA approval for treating…

The use of an electronic template and a uniform workflow improved adherence to AAP evidence-based guidelines for the treatment of attention-deficit hyperactivity disorder with stimulant medication, according to data presented at the 2015 AAP National Conference and Exhibition

Pet ownership and brief human–animal interactions can serve as a form of social support and convey a host of beneficial psychological and physiological health benefits. This article critically examines recent relevant literature on the pet–health connection

Dramatic increases in exposure to toxic chemicals in the last four decades are threatening human reproduction and health, according to the International Federation of Gynecology and Obstetrics (FIGO), the first global reproductive health organization to take a stand on human exposure to toxic chemicals.

There’s evidence that preemies are born with weak connections in some critical brain networks, including those involved in focus, social interactions, and emotional processing, researchers reported at the Society for Neuroscience meeting in Chicago.

Researchers say a drug called atomoxetine, when paired with parent coaching, can significantly reduce the manifestations of attention deficit hyperactivity disorder (ADHD) in children with autism.

Rates of attention deficit hyperactivity disorder (ADHD) drop as elevation increases, according to findings published in the Journal of Attention Disorders.

Results from a 13-week, multicenter, randomized, double blind, placebo-controlled trial indicate guanfacine extended-release was associated with significant improvement in attention deficit/hyperactivity disorder symptoms in adolescents.

Behind the Wheel With ADHD provides driving instructors with additional training to understand the risks associated with ADHD and teen driving. Instructors are trained in the use of new tools, technologies, and strategies designed to help teens with ADHD learn to drive more safely.

Brain training, or neurofeedback, has been around for a long time. Now, new technology and research on its effectiveness have created new interest in the field. Patients are using neurofeedback instead of medications to help with a variety of conditions from migraines and stress to severe anxiety.

This continuing medical education activity is intended for psychiatrists, psychologists, primary care physicians, physician assistants, nurse practitioners, and other health care professionals who seek to improve their care for patients with mental health disorders.

Perhaps what makes it even more difficult to live with ADHD is the amount of misinformation and negative stereotypes that surround the diagnosis. ADHD patients are often written off as over-diagnosed, undisciplined, or simply lazy. The list below examines some of these myths.